• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂因素对伏立康唑滴眼液体外角膜透过性的影响。

Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

作者信息

Mohanty Biswaranjan, Mishra Sagar Kumar, Majumdar Dipak K

机构信息

Department of Pharmaceutics, Seemanta Institute of Pharmaceutical Sciences, Jharpokharia, Mayurbhanj, Orissa, India.

Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Orissa, India.

出版信息

J Adv Pharm Technol Res. 2013 Oct;4(4):210-6. doi: 10.4103/2231-4040.121416.

DOI:10.4103/2231-4040.121416
PMID:24350052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3853698/
Abstract

The purpose of this research was to evaluate the effect the formulation factors on in vitro permeation of voriconazole through freshly isolated goat and sheep corneas. An increase in the pH of the drops from 4.0 to 8.0 resulted in significant (P < 0.05) increase drug permeation. Raising concentration of the drops from 0.05% to 0.2% (w/v) significantly, (P < 0.05) increased drug permeation, but decreased the percent permeation. Corneal transport of voriconazole is both pH and concentration dependent. Eye drops containing disodium edetate (ethylenediaminetetraacetic acid) alone or combination with benzalkonium chloride showed significantly (P < 0.05) higher permeation as compared with control formulation. Addition of beta-cyclodextrin to the formulation enhanced corneal permeation of voriconazole. Compared with control formulation, voriconazole 0.2% (w/v) drop containing viscosity modifier produced significant (P < 0.05) decrease in permeation. Most of the formulations showed higher zone of inhibition against Candida albicans.

摘要

本研究的目的是评估制剂因素对伏立康唑通过新鲜分离的山羊和绵羊角膜的体外渗透作用的影响。滴眼液的pH值从4.0增加到8.0会导致药物渗透显著增加(P<0.05)。将滴眼液的浓度从0.05%提高到0.2%(w/v)可显著增加(P<0.05)药物渗透,但渗透百分比会降低。伏立康唑的角膜转运既依赖于pH值也依赖于浓度。与对照制剂相比,单独含有依地酸二钠(乙二胺四乙酸)或与苯扎氯铵联合使用的滴眼液显示出显著更高(P<0.05)的渗透率。向制剂中添加β-环糊精可增强伏立康唑的角膜渗透。与对照制剂相比,含有粘度调节剂的0.2%(w/v)伏立康唑滴眼液的渗透率显著降低(P<0.05)。大多数制剂对白色念珠菌显示出更高的抑菌圈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/866378831176/JAPTR-4-210-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/9487c8c0611c/JAPTR-4-210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/65e5374d6b9d/JAPTR-4-210-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/866378831176/JAPTR-4-210-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/9487c8c0611c/JAPTR-4-210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/65e5374d6b9d/JAPTR-4-210-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c6b/3853698/866378831176/JAPTR-4-210-g009.jpg

相似文献

1
Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.制剂因素对伏立康唑滴眼液体外角膜透过性的影响。
J Adv Pharm Technol Res. 2013 Oct;4(4):210-6. doi: 10.4103/2231-4040.121416.
2
Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.防腐剂、抗氧化剂和增粘剂对酮咯酸氨丁三醇体外角膜渗透的影响。
Indian J Exp Biol. 2002 May;40(5):555-9.
3
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.制剂因素对莫西沙星滴眼液经山羊、绵羊和水牛离体角膜体外渗透的影响。
AAPS PharmSciTech. 2006 Mar;7(1):E89. doi: 10.1208/pt070113. Epub 2017 Mar 8.
4
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.制剂因素对莫西沙星滴眼液经离体山羊、绵羊和水牛角膜体外渗透的影响。
AAPS PharmSciTech. 2006 Feb 10;7(1):E13. doi: 10.1208/pt070113.
5
Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.制剂因素对加替沙星滴眼液体外角膜透过性的影响。
AAPS PharmSciTech. 2006 Jul 7;7(3):57. doi: 10.1208/pt070357.
6
Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.伏立康唑滴眼液治疗真菌性角膜炎的设计与评价
J Pharm (Cairo). 2014;2014:490595. doi: 10.1155/2014/490595. Epub 2014 Apr 29.
7
Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.浓度、pH值和防腐剂对布洛芬和氟比洛芬从非缓冲水性滴眼液中的体外角膜渗透的影响。
Indian J Exp Biol. 1997 Aug;35(8):844-9.
8
In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.酮咯酸从油基滴眼液和眼膏的体外角膜渗透情况。
Indian J Exp Biol. 1997 Dec;35(12):1324-30.
9
In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.莫西沙星从油滴透过离体山羊、绵羊、水牛和兔角膜的体外渗透特性。
Pharmazie. 2007 Nov;62(11):853-7.
10
Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.双氯芬酸滴眼液经离体山羊、绵羊和水牛角膜的体外透角膜途径的效果。
ScientificWorldJournal. 2015;2015:432376. doi: 10.1155/2015/432376. Epub 2015 Jan 13.

引用本文的文献

1
Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.载有特康唑的边缘活化混合弹性脂质体用于改善眼部真菌病中的角膜渗透:体外表征、统计优化、微生物学评估和体内评价。
Int J Pharm X. 2025 Apr 8;9:100333. doi: 10.1016/j.ijpx.2025.100333. eCollection 2025 Jun.
2
Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.探索载有抗真菌药物的前体脂质体增强真菌性角膜炎角膜渗透的潜力:从实验室表征到微生物学评估的全面研究
Int J Pharm X. 2025 Feb 24;9:100322. doi: 10.1016/j.ijpx.2025.100322. eCollection 2025 Jun.
3

本文引用的文献

1
Nanoparticles laden in situ gelling system for ocular drug targeting.用于眼部药物靶向的载纳米颗粒原位凝胶系统。
J Adv Pharm Technol Res. 2013 Jan;4(1):9-17. doi: 10.4103/2231-4040.107495.
2
Voriconazole in the treatment of fungal eye infections: a review of current literature.伏立康唑治疗真菌性眼部感染:当前文献综述
Br J Ophthalmol. 2008 Jul;92(7):871-8. doi: 10.1136/bjo.2007.136515.
3
Use of voriconazole in the treatment of fungal keratitis.伏立康唑在真菌性角膜炎治疗中的应用。
Expanding Arsenal against Ocular Diseases through Nanoemulsion: Success So Far and the Road Ahead.通过纳米乳剂扩展抗眼部疾病的武器库:迄今为止的成功与未来之路。
Curr Drug Deliv. 2024 Jul 15. doi: 10.2174/0115672018286288240705064730.
4
Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole.壳聚糖包衣的固体脂质纳米粒:一种用于甲硝唑眼部给药的潜在系统。
Pharmaceutics. 2023 Jun 30;15(7):1855. doi: 10.3390/pharmaceutics15071855.
5
A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration.关于通过不同给药途径增强硝酸戊四唑纳米系统抗真菌活性的最新综述。
Drug Deliv. 2023 Dec;30(1):2179129. doi: 10.1080/10717544.2023.2179129.
6
Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management.Olaminosomes 作为纳米结构平台在眼部念珠菌病治疗中的明显封顶效应。
Drug Deliv. 2022 Dec;29(1):2945-2958. doi: 10.1080/10717544.2022.2120926.
7
Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: Preparation, characterization, and assessments.载有硝酸芬替康唑的角膜靶向诺瓦索姆用于眼部念珠菌病的治疗:制备、表征和评估。
Drug Deliv. 2022 Dec;29(1):2428-2441. doi: 10.1080/10717544.2022.2103600.
8
Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants.用于眼科应用的纳米乳剂的开发与表征:阳离子表面活性剂的作用
Materials (Basel). 2021 Dec 8;14(24):7541. doi: 10.3390/ma14247541.
9
Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.眼科纳米乳剂:从组成到技术工艺和质量控制。
Mol Pharm. 2021 Oct 4;18(10):3719-3740. doi: 10.1021/acs.molpharmaceut.1c00650. Epub 2021 Sep 17.
10
Effect of Smartphone Light Fluxes on Cornea: A Biophysical Study.智能手机光通量对角膜的影响:一项生物物理学研究。
J Med Phys. 2020 Jul-Sep;45(3):187-194. doi: 10.4103/jmp.JMP_89_19. Epub 2020 Oct 13.
Int Ophthalmol Clin. 2007 Spring;47(2):47-59. doi: 10.1097/IIO.0b013e318036bd47.
4
Fungal keratitis in Melbourne.墨尔本的真菌性角膜炎
Clin Exp Ophthalmol. 2007 Mar;35(2):124-30. doi: 10.1111/j.1442-9071.2006.01405.x.
5
Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.制剂因素对加替沙星滴眼液体外角膜透过性的影响。
AAPS PharmSciTech. 2006 Jul 7;7(3):57. doi: 10.1208/pt070357.
6
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.制剂因素对莫西沙星滴眼液经离体山羊、绵羊和水牛角膜体外渗透的影响。
AAPS PharmSciTech. 2006 Feb 10;7(1):E13. doi: 10.1208/pt070113.
7
Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.马匹局部和口服给药后房水中伏立康唑浓度的评估。
Am J Vet Res. 2006 Feb;67(2):296-301. doi: 10.2460/ajvr.67.2.296.
8
Topical voriconazole as a novel treatment for fungal keratitis.局部用伏立康唑作为真菌性角膜炎的一种新疗法。
Antimicrob Agents Chemother. 2006 Jan;50(1):262-8. doi: 10.1128/AAC.50.1.262-268.2006.
9
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.伏立康唑和卡泊芬净治疗内源性真菌性眼内炎
Am J Ophthalmol. 2005 Jan;139(1):135-40. doi: 10.1016/j.ajo.2004.08.077.
10
Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.玻璃体内注射伏立康唑的安全性:视网膜电图和组织病理学研究。
Trans Am Ophthalmol Soc. 2003;101:183-9; discussion 189.